Search

Biswajit Biswas

from Germantown, MD
Age ~62

Biswajit Biswas Phones & Addresses

  • Germantown, MD
  • 9308 Cherry Hill Rd, College Park, MD 20740
  • Greenbelt, MD
  • Frederick, MD
  • Rockville, MD

Publications

Wikipedia References

Biswajit Biswas Photo 9

Biswajit Biswas

Us Patents

Size-Variable Strain-Specific Protective Antigen For Potomac Horse Fever

View page
US Patent:
20040191262, Sep 30, 2004
Filed:
Jan 23, 2002
Appl. No.:
10/055536
Inventors:
Sukanta Dutta - Glenn Dale MD, US
Biswajit Biswas - Greenbelt MD, US
Ramesh Vemulapalli - Blacksburg VA, US
International Classification:
A61K039/00
A61K039/38
US Classification:
424/184100
Abstract:
An isolated and purified antigen which is expressed by a wild-type strain and is specific to the strain. The present invention also relates to nucleic acid constructs which encode the antigen, expression vectors, transformed host cells, and methods for producing the antigen.

Immunologically Enhanced Recombinant Vaccines

View page
US Patent:
20070207167, Sep 6, 2007
Filed:
Dec 26, 2006
Appl. No.:
11/645817
Inventors:
Carl Merril - Bethesda MD, US
Biswajit Biswas - Germantown MD, US
Michael McKinstry - Bethesda MD, US
International Classification:
A61K 39/12
C12N 15/86
C12N 7/00
US Classification:
424199100, 435235100, 435456000
Abstract:
The present invention is directed to recombinant vaccines, based on a phage vector system, which enhance immunological response and allow rapid construction and deployment of vaccines.

Size-Variable Strain-Specific Protective Antigen For Potomac Horse Fever

View page
US Patent:
20080069824, Mar 20, 2008
Filed:
Nov 3, 2005
Appl. No.:
11/266053
Inventors:
Sukanta Dutta - Glenn Dale MD, US
Biswajit Biswas - Greenbelt MD, US
Ramesh Vemulapalli - Blacksburg VA, US
International Classification:
A61K 39/00
A61P 43/00
US Classification:
4241841
Abstract:
An isolated and purified antigen which is expressed by a wild-type strain and is specific to the stain. The present invention also relates to nucleic acid constructs which encode the antigen, expression vectors, transformed host cells, and methods for producing the antigen.

Size-Variable Strain-Specific Protective Antigen For Potomac Horse Fever

View page
US Patent:
6375954, Apr 23, 2002
Filed:
Sep 18, 1998
Appl. No.:
09/157257
Inventors:
Sukanta Dutta - Glenn Dale MD
Biswajit Biswas - Greenbelt MD
Ramesh Vemulapalli - Blacksburg VA
Assignee:
University of Maryland College Park - College Park MD
International Classification:
A61K 3902
US Classification:
4242341, 4241841, 4241851, 4241911, 4242651, 5303501
Abstract:
An isolated and purified antigen which is expressed by a wild-type strain and is specific to the strain. The present invention also relates to nucleic acid constructs which encode the antigen, expression vectors, transformed host cells, and methods for producing the antigen.

Bacteriophage Compositions And Methods Of Selection Of Components Against Specific Bacteria

View page
US Patent:
20230079967, Mar 16, 2023
Filed:
Aug 16, 2022
Appl. No.:
17/820035
Inventors:
- Silver Spring MD, US
Biswajit Biswas - Germantown MD, US
Matthew S. Henry - Thurmont MD, US
Assignee:
United States of America as Represented by the Secretary of the Navy - Silver Spring MD
International Classification:
C40B 40/02
A61K 35/76
C12N 7/00
C12Q 1/18
Abstract:
The subject matter of the instant invention relates to methods of compounding compositions comprising bacteriophage effective for treating bacterial infections, including but not limited to, multidrug resistant bacterial infections. The invention also relates to compositions, bacterial diversity sets, and phage libraries prepared according to the methods of the instant invention.

Phage-Mediated Molecular Detection Methods And Related Aspects

View page
US Patent:
20200308622, Oct 1, 2020
Filed:
May 6, 2020
Appl. No.:
16/868384
Inventors:
Biswajit Biswas - Germantown MD, US
Francisco Jesus Malagon Bautista - Germantown MD, US
Luis Angel Estrella - Silver Spring MD, US
Assignee:
United States of America as represented by the Secretary of the Navy - Silver Spring MD
International Classification:
C12Q 1/14
C12N 7/00
C12Q 1/18
C12Q 1/6806
C07K 14/005
C12Q 1/70
C12Q 1/689
Abstract:
Methods of detecting actively growing host organisms, including bacterial organisms, involving the detection of ribonucleic acid (RNA) products produced by unmodified infectious bioagents that infect the host organisms are provided. Related methods of assessing drug susceptibility and resistance are further provided. In addition to these surrogate detection methods, related reaction mixtures, kits, systems, and microfluidic cards are also provided.

Bacteriophage Compositions And Methods Of Selection Of Components Against Specific Bacteria

View page
US Patent:
20190365834, Dec 5, 2019
Filed:
Jun 7, 2019
Appl. No.:
16/434320
Inventors:
- Silver Spring MD, US
Biswajit Biswas - Germantown MD, US
Matthew S. Henry - Thurmont MD, US
Assignee:
United States of America as Represented by the Secretary of the Navy - Silver Spring MD
International Classification:
A61K 35/76
C12N 7/00
C12Q 1/18
Abstract:
The subject matter of the instant invention relates to methods of compounding compositions comprising bacteriophage effective for treating bacterial infections, including but not limited to, multidrug resistant bacterial infections. The invention also relates to compositions, bacterial diversity sets, and phage libraries prepared according to the methods of the instant invention.

Phage-Mediated Molecular Detection Methods And Related Aspects

View page
US Patent:
20180346958, Dec 6, 2018
Filed:
May 31, 2018
Appl. No.:
15/994855
Inventors:
Biswajit Biswas - Germantown MD, US
Francisco Jesus Malagon Bautista - Germantown MD, US
Luis Angel Estrella - Silver Spring MD, US
Assignee:
United States of America as represented by the Secretary of the Navy - Silver Spring MD
International Classification:
C12Q 1/14
C12N 7/00
C07K 14/005
C12Q 1/6806
C12Q 1/18
Abstract:
Methods of detecting actively growing host organisms, including bacterial organisms, involving the detection of ribonucleic acid (RNA) products produced by unmodified infectious bioagents that infect the host organisms are provided. Related methods of assessing drug susceptibility and resistance are further provided. In addition to these surrogate detection methods, related reaction mixtures, kits, systems, and microfluidic cards are also provided.
Biswajit Biswas from Germantown, MD, age ~62 Get Report